Groundwork BioAg
PrivateLast Round
Grant
Jul 2, 2024
Total Funding Raised
$24.6M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Groundwork BioAg operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Grant round in July 2024.
Groundwork BioAg is a bioagriculture company that produces highly-concentrated, cost-effective mycorrhizal inoculants to enhance crop performance and soil health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Carbon Capture, Environmental Monitoring
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Groundwork BioAg Comparables
Compare Groundwork BioAg with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NewLeaf Symbiotics | 82% | |
| BioConsortia, Inc. | 79% | |
| Loam Bio | 79% |
For institutional investors. Book with your work email.
Groundwork BioAg Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 2, 2024 | ||||
| Grant | Nov 21, 2023 | ||||
| Series B | Aug 18, 2022 | ||||
| VC Round | May 12, 2021 | ||||
| Series A Extension | Nov 1, 2016 | ||||
Grant | Dec 30, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Groundwork BioAg Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Edaphon | Series B |
| bpd partners | VC Round |
| BIRD Foundation | Grant |
| Ibex Investors | Series B, VC Round |
| MoreVC | Seed, Series B, Series A, VC Round |
| SRK Management Company | Series B |
| ProDelta | VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 141% MoM, reaching 8.7K.
- Jul 24, 2026
Monthly visitors increased 45% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asOct 14, 2026
Groundwork BioAg, Ltd.'s Rootella Carbon program receives a 'BBB' rating from BeZero Carbon, placing it among the highest-rated agricultural soil carbon projects, in Israel on Oct 14th '26.
For institutional investors. Book with your work email.
Groundwork BioAg Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Groundwork BioAg's valuation, stock price, and market status.
Is Groundwork BioAg a public or private company?
Groundwork BioAg is a private company.
What is the current stock price of Groundwork BioAg?
Groundwork BioAg is a private company, so its shares have no public market price. Caplight tracks Groundwork BioAg's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Groundwork BioAg worth (valuation)?
Valuation information for Groundwork BioAg is not publicly available.
Can I buy Groundwork BioAg stock?
Groundwork BioAg shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Groundwork BioAg's last funding round?
Groundwork BioAg's most recent funding round was Grant on July 2, 2024.
Who are the main investors in Groundwork BioAg?
Key investors in Groundwork BioAg include Ibex Investors, Climate Innovation Capital.
Will Groundwork BioAg IPO soon?
No public IPO plans have been announced for Groundwork BioAg.
How can I track Groundwork BioAg secondary market activity?
Caplight tracks bids, offers, and trades in Groundwork BioAg's shares on secondary markets.